Cryo Cell International (CCEL) Total Non-Current Liabilities (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Total Non-Current Liabilities data on file, last reported at $79.2 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 264.79% year-over-year to $79.2 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $79.2 million (up 264.79% YoY) and the FY2025 annual result came in at $19.8 million, down 74.57% from the prior year.
• Total Non-Current Liabilities grew to $79.2 million in Q1 2026 per CCEL's latest filing, from $19.8 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $79.2 million in Q1 2026 and bottomed at $17.4 million in Q3 2024.
• The 5-year median for Total Non-Current Liabilities is $50.0 million (2022), against an average of $45.7 million.
• The widest annual swing landed in 2024, when Total Non-Current Liabilities plunged 74.67%; it then soared 347.43% in 2025.
• Tracing CCEL's Total Non-Current Liabilities over 5 years: stood at $19.5 million in 2022, then increased by 7.1% to $20.9 million in 2023, then surged by 273.11% to $77.8 million in 2024, then tumbled by 74.57% to $19.8 million in 2025, then surged by 300.33% to $79.2 million in 2026.
• Per Business Quant, the three latest CCEL Total Non-Current Liabilities figures stand at $79.2 million (Q1 2026), $19.8 million (Q4 2025), and $78.0 million (Q3 2025).

Peer Comparison